Ignite Creation Date:
2024-10-25 @ 7:50 PM
Last Modification Date:
2024-10-26 @ 3:42 PM
Study NCT ID:
NCT06629857
Status:
COMPLETED
Last Update Posted:
None
First Post:
2024-10-04
Brief Title:
A Cross Sectional Study Evaluating the Mean Levels of Alpha Fetoprotein in Patients of Hepatocellular Carcinoma and Its Correlates in Pakistan
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Clinical Correlation of Alpha-Fetoprotein in Hepatocellular Carcinoma a Cross-Sectional Study from Southeast Asia
Status:
COMPLETED
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study aims to explore the levels of alpha-fetoprotein AFP a protein often elevated in liver cancer in patients with hepatocellular carcinoma HCC The goal is to determine whether AFP levels vary based on the size of the liver tumor or other health conditions like hepatitis B hepatitis C and obesity By analyzing data from 94 patients the study seeks to identify factors that influence AFP levels which may help in understanding liver cancer progression and improving diagnosis and treatment approaches
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None